Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Bone Marrow Transplant ; 33(12): 1173-9, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15094754

RESUMEN

We conducted a nationwide survey to define incidence of deep fungal infections and fungal prophylaxis practices after HSCT. In all, 63 institutions responded. Total number of in-patient transplantations was 935: 367 autologous, 414 allogeneic myeloablative, and 154 allogeneic reduced-intensity (RIST) (n=154). Number of patients who were cared for in a clean room at transplant was 261 (71%) in autologous, 409 (99%) in conventional and 93 (66%) in RIST, respectively. All patients received prophylactic antifungal agents; 89% fluconazole. Number of patients who received the dosage recommended in the CDC guidelines (400 mg/day) was 135 (42%) in conventional transplant and 34 (30%) in RIST (P=0.037). Number of patients who received fluconazole until engraftment and beyond day 75 in conventional transplant vs RIST was, respectively, 324 (100%) vs 109 (97%), and 39 (12%) vs 18 (16%), with no significant difference between the two groups. A total of 37 patients (4.0%) were diagnosed with deep fungal infections; autologous transplantation (0.03%), conventional transplantation (6.0%) and RIST (7.1%). Wide variations in antifungal prophylaxis practice according to the type of transplant and the institutions, and deep fungal infection remain significant problems in RIST.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Micosis/epidemiología , Micosis/prevención & control , Premedicación/estadística & datos numéricos , Antifúngicos/uso terapéutico , Recolección de Datos , Fluconazol/uso terapéutico , Enfermedades Hematológicas/complicaciones , Enfermedades Hematológicas/terapia , Trasplante de Células Madre Hematopoyéticas/métodos , Trasplante de Células Madre Hematopoyéticas/estadística & datos numéricos , Humanos , Incidencia , Japón , Micosis/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Estudios Retrospectivos , Acondicionamiento Pretrasplante/métodos , Acondicionamiento Pretrasplante/estadística & datos numéricos , Trasplante Autólogo/estadística & datos numéricos , Trasplante Homólogo/estadística & datos numéricos
2.
Gene Ther ; 11(9): 784-90, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-14961067

RESUMEN

Sendai virus (SeV) vector-mediated gene delivery of glial cell line-derived neurotrophic factor (GDNF) and nerve growth factor (NGF) prevented the delayed neuronal death induced by transient global ischemia in gerbils, even when the vector was administered several hours after ischemia. Intraventricular administration of SeV vector directed high-level expression of the vector-encoded neurotrophic factor genes, which are potent candidates for the treatment of neurodegenerative diseases. After occlusion of the bilateral carotid arteries of gerbils, SeV vector carrying GDNF (SeV/GDNF), NGF (SeV/NGF), brain-derived neurotrophic factor (SeV/BDNF), insulin-like growth factor-1 (SeV/IGF-1) or vascular endothelial growth factor (SeV/VEGF) was injected into the lateral ventricle. Administration of SeV/GDNF, SeV/NGF or SeV/BDNF 30 min after the ischemic insult effectively prevented the delayed neuronal death of the hippocampal CA1 pyramidal neurons. Furthermore, the administration of SeV/GDNF or SeV/NGF as late as 4 or 6 h after the ischemic insult also prevented the death of these neurons. These results indicate that SeV vector-mediated gene transfer of neurotrophic factors has high therapeutic potency for preventing the delayed neuronal death induced by transient global ischemia, and provides an approach for gene therapy of stroke.


Asunto(s)
Isquemia Encefálica/terapia , Terapia Genética/métodos , Factor de Crecimiento Nervioso/genética , Neuronas/patología , Animales , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patología , Muerte Celular/genética , Técnicas de Transferencia de Gen , Gerbillinae , Factor Neurotrófico Derivado de la Línea Celular Glial , Hipocampo/metabolismo , Factor de Crecimiento Nervioso/metabolismo , Factores de Crecimiento Nervioso/genética , Factores de Crecimiento Nervioso/metabolismo , Virus Sendai/genética
3.
Gene ; 275(1): 141-8, 2001 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-11574162

RESUMEN

Here we purified and identified a myosin II kinase from sea urchin eggs. The activity of this myosin II kinase in the egg extract was not significantly affected by Ca(2+)/calmodulin (CaM). Using sequential column chromatographies, we purified the myosin II kinase from the egg extract as a complex composed of 36- (p36) and 28-kDa (p28) proteins. Partial amino acid sequences of these two components were highly coincident with those of the alpha and beta subunits of protein kinase CK2 (formerly casein kinase II) in sea urchin eggs, respectively. To confirm that the purified myosin II kinase was CK2, we obtained a cDNA which encodes p36 from a cDNA library of sea urchin eggs. The amino acid sequence derived from the obtained cDNA showed over 70% homology to CK2 from various eukaryotes. Furthermore, recombinant p36, as well as the purified myosin II kinase, phosphorylated MRLC. One dimensional phosphopeptide mapping revealed that the phosphorylation site(s) of MRLC by both recombinant p36 and the purified myosin II kinase was identical. These clearly showed that the Ca(2+)/CaM-independent myosin II kinase activity in sea urchin eggs was identical to CK2.


Asunto(s)
Óvulo/metabolismo , Proteínas Serina-Treonina Quinasas/genética , Erizos de Mar/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Quinasa de la Caseína II , Sistema Libre de Células/enzimología , ADN Complementario/química , ADN Complementario/genética , Electroforesis en Gel de Poliacrilamida , Femenino , Células HeLa , Humanos , Datos de Secuencia Molecular , Cadenas Ligeras de Miosina/metabolismo , Miosinas/metabolismo , Óvulo/enzimología , Fosforilación , Proteínas Serina-Treonina Quinasas/aislamiento & purificación , Proteínas Serina-Treonina Quinasas/metabolismo , Erizos de Mar/enzimología , Alineación de Secuencia , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido
4.
Gene Ther ; 8(14): 1043-50, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11526451

RESUMEN

We scrutinized the applicability and efficacy of Sendai virus (SeV) vectors expressing either LacZ or human insulin-like growth factor-I (hIGF-I) in gene transfer into skeletal muscle. Seven days after the intramuscular injection of LacZ/SeV X-gal labeled myofibers were demonstrated in rat anterior tibialis muscle with/without bupivacaine treatment and the transgene expression persisted up to 1 month after injection. Recombinant hIGF-I was detected as a major protein species in culture supernatants of a neonatal rat myoblast cell line L6 and thus induced the cells to undergo myogenetic differentiation. The introduction of hIGF-I/SeV into the muscle showed a significant increase in regenerating and split myofibers which were indicative of hypertrophy, and also an increase in the total number of myofibers, in comparison to that seen in the LacZ/SeV-treated control muscle. These results demonstrate that SeV achieves high-level transgene expression in skeletal muscle, and that hIGF-I gene transfer using SeV vector may therefore have great potential in the treatment of neuromuscular disorders.


Asunto(s)
Terapia Genética/métodos , Vectores Genéticos/administración & dosificación , Factor I del Crecimiento Similar a la Insulina/genética , Músculo Esquelético/fisiología , Enfermedades Neuromusculares/terapia , Regeneración , Animales , Células Cultivadas , Expresión Génica , Miembro Posterior , Humanos , Inyecciones Intramusculares , Factor I del Crecimiento Similar a la Insulina/análisis , Operón Lac , Masculino , Modelos Animales , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/análisis , Respirovirus/genética , Transfección/métodos , Transgenes
5.
Talanta ; 46(6): 1293-7, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18967256

RESUMEN

The concentration of potassium was determined by a combination of flow injection analysis (FIA) with an all-solid-state potassium sensor detection. The all-solid-state potassium-selective electrode possessing long-term potential stability was fabricated by coating an electroactive polypyrrole/poly(4-styrenesulfonate) film electrode with a plasticized poly(vinyl chloride) membrane containing valinomycin. The simple FIA system developed in this laboratory demonstrated sensitivity identical to that in the batch system and achieved considerably rapid assay (150 samples h(-1)). Analyses of soy sauce and control serum samples by this FIA system yielded results in good agreement with those obtained by conventional measurements.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA